The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
CHEK2 Is a Multiorgan Cancer Susceptibility Gene
Open accessAbstract
A single founder allele of the CHEK2 gene has been associated with predisposition to breast and prostate cancer in North America and Europe. The CHEK2 protein participates in the DNA damage response in many cell types and is therefore a good candidate for a multisite cancer susceptibility gene. Three founder alleles are present in Poland. Two of these result in a truncated CHEK2 protein, and the other is a missense substitution of an isoleucine for a threonine. We ascertained the prevalence of each of these alleles in 4,008 cancer cases and 4,000 controls, all from Poland. The majority of the common cancer sites were represented. Positive associations with protein-truncating alleles were seen for cancers of the thyroid (odds ratio [OR] 4.9; P=.0006), breast (OR 2.2; P=.02), and prostate (OR 2.2; P=.04). The missense variant I157T was associated with an increased risk of breast cancer (OR 1.4; P=.02), colon cancer (OR 2.0; P=.001), kidney cancer (OR 2.1; P=.0006), prostate cancer (OR 1.7; P=.002), and thyroid cancer (OR 1.9; P=.04). The range of cancers associated with mutations of the CHEK2 gene may be much greater than previously thought.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322
The CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis
Falck, J., Mailand, N., Syljuåsen, R. G., Bartek, J., & Lukas, J. (2001) · Nature · doi:10.1038/35071124 · Cited by 1,085
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 904
(2004) · The American Journal of Human Genetics · doi:10.1086/421251 · Cited by 471
Mutations in CHEK2 Associated with Prostate Cancer Risk
Dong, X., Wang, L., Taniguchi, K., Wang, X., Cunningham, J. M., McDonnell, S. K., Qian, C., Marks, A. F., Slager, S. L., Peterson, B. J., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/346094 · Cited by 308
Li, J., Williams, B. L., Haire, L. F., Goldberg, M., Wilker, E., Durocher, D., Yaffe, M. B., Jackson, S. P., & Smerdon, S. J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00527-0 · Cited by 232
Meijers-Heijboer, H., Wasielewski, M., Wagner, A., Hollestelle, A., Elstrodt, F., van den Bos, R., de Snoo, A., Tjon A Fat, G., Brekelmans, C., Jagmohan, S., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375121 · Cited by 227
Vahteristo, P., Tamminen, A., Karvinen, P., Eerola, H., Eklund, C., Aaltonen, L. A., BLOMQVIST, C. P., Aittomäki, K., & Nevanlinna, H. A. (2001) · PubMed · Cited by 180
CHEK2 variant I157T may be associated with increased breast cancer risk
Kilpivaara, O., Vahteristo, P., Falck, J., Syrjäkoski, K., Eerola, H., Easton, D., Bartkova, J., Lukas, J., Heikkilä, P., Aittomäki, K., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20299 · Cited by 163
A Novel Founder CHEK2 Mutation is Associated with Increased Prostate Cancer Risk
Cybulski, C., Huzarski, T., Górski, B., Masojć, B., Mierzejewski, M., Dębniak, T., Gliniewicz, B., Trubicka, J., Złowocka, E., Kurzawski, G., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0341 · Cited by 158
Self-citationCHEK2 variants associate with hereditary prostate cancer
Seppälä, E. H., Ikonen, T., Mononen, N., Autio, V., Rökman, A., Matikainen, M. P., Tammela, T. L. J., & Schleutker, J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601425 · Cited by 147
Frequency of CHEK2*1100delC in New York breast cancer cases and controls
Offit, K., Pierce, H., Kirchhoff, T., Kolachana, P., Rapaport, B., Gregersen, P. K., Johnson, S., Yossepowitch, O., Huang, H. J., Satagopan, J. M., et al. (2003) · BMC Medical Genetics · doi:10.1186/1471-2350-4-1 · Cited by 137
Schutte, M. E. M., Seal, S., Barfoot, R., Meijers-Heijboer, H. E. J., Wasielewski, M., Evans, D. G., Eccles, D., Meijers, C., Lohman, F. P., Klijn, J. G. M., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/373965 · Cited by 136
Falck, J., Lukas, C., Protopopova, M., Lukas, J., Selivanova, G., & Bártek, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204811 · Cited by 117
Limited relevance of the CHEK2 gene in hereditary breast cancer
Dufault, M. R., Betz, B., Wappenschmidt, B., Hofmann, W., Bandick, K., Golla, A., Pietschmann, A., Nestle-Krämling, C., Rhiem, K., Hüttner, C., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20073 · Cited by 94
Sodha, N., Williams, R., Mangion, J., Bullock, S. L., Yuille, M., & Eeles, R. A. (2000) · Science · doi:10.1126/science.289.5478.359a · Cited by 80
CHEK2 1100delC and colorectal cancer
Kilpivaara, O., Laiho, P., Aaltonen, L. A., & Nevanlinna, H. A. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.10.e110 · Cited by 47
Cited by
Nebert, D. W., & Dalton, T. P. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2015 · Cited by 958
Lynch, H., Lynch, P., Lanspa, S., Snyder, C., Lynch, J., & Boland, C. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01230.x · Cited by 840
Inherited causes of clonal haematopoiesis in 97,691 whole genomes
Bick, A. G., Weinstock, J. S., Nandakumar, S. K., Fulco, C. P., Bao, E. L., Zekavat, S. M., Szeto, M. D., Liao, X., Leventhal, M. J., Nasser, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2819-2 · Cited by 733
Spectrum of Mutations in BRCA1, BRCA2, CHEK2, and TP53 in Families at High Risk of Breast Cancer
Walsh, T., Casadei, S., Coats, K. H., Swisher, E., Stray, S. M., Higgins, J., Roach, K. C., Mandell, J., Lee, M. K., Ciernikova, S., et al. (2006) · JAMA · doi:10.1001/jama.295.12.1379 · Cited by 666
Abnet, C. C., Freedman, N. D., Hu, N., Wang, Z., Yu, K., Shu, X.-O., Yuan, J.-M., Zheng, W., Dawsey, S. M., Dong, L. M., et al. (2010) · Nature Genetics · doi:10.1038/ng.649 · Cited by 487
Metadata
- Authors
- Cybulski, C., Górski, B., Huzarski, T., Masojć, B., Mierzejewski, M., Dębniak, T., Teodorczyk, U., Byrski, T., Gronwald, J., Matyjasik, J., Złowocka, E., Lenner, M., Grabowska, E., Nej, K., Castaneda, J., Mędrek, K., Szymańska, A., Szymańska, J., Kurzawski, G., Suchy, J., Oszurek, O., Witek, A., Narod, S. A., & Lubiński, J.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 75
- Issue
- 6
- Pages
- 1131-1135
- ISSN
- 0002-9297 (ISSN-L)
- OpenAlex
- W1985764154
- Cited by
- 551
- References
- 18
- FWCI
- 11.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.